vimarsana.com

Latest Breaking News On - Aileron therapeutics inc - Page 1 : vimarsana.com

Aileron Therapeutics, Inc (NASDAQ:ALRN) Major Shareholder Sells 6,291 Shares

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) major shareholder Of Texas/Texas Am I. University sold 6,291 shares of the firm’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $3.30, for a total value of $20,760.30. Following the transaction, the insider now owns 1,783,851 shares in […]

Aileron Therapeutics (NASDAQ:ALRN) Issues Quarterly Earnings Results

Aileron Therapeutics (NASDAQ:ALRN – Get Free Report) released its earnings results on Monday. The company reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.72), Zacks reports. Aileron Therapeutics Stock Performance Shares of NASDAQ ALRN opened at $3.77 on Wednesday. Aileron Therapeutics has a fifty-two week low of $1.01 […]

Aileron Therapeutics (NASDAQ:ALRN) Announces Quarterly Earnings Results, Misses Estimates By $0 72 EPS

Aileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.72), Zacks reports. Aileron Therapeutics Stock Down 1.9 % Shares of ALRN traded down $0.07 during trading hours on Wednesday, reaching $3.70. 6,496 shares […]

Reviewing Aileron Therapeutics (NASDAQ:ALRN) & Atreca (NASDAQ:BCEL)

Aileron Therapeutics (NASDAQ:ALRN – Get Free Report) and Atreca (NASDAQ:BCEL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk. Profitability This table compares Aileron Therapeutics and Atreca’s […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.